Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-343-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20110308.22.2-343-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"As the draft report already covered most of the relevant issues, there was no need to table many amendments. While we, the Greens/EFA, co-signed a number of amendments with the rapporteur and shadow rapporteurs, we were the only ones to try to introduce criticism of the current model of drug development based on patents, which leads to high prices for medical innovation and lack of access to affordable essential medicines. We called for new models of medical innovation and for tackling the lack of access to affordable essential medicines. We called for new models of medical research (innovation prize schemes, equitable licensing, patent pools, public/private partnerships and social conditionality in the concession of EU research funding), but these amendments were not adopted."@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples